methylphenidate

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 113-45-1

Where It Comes From

10 FDA-registered drug labelers
Ascent Pharmaceuticals, Inc.
Cambrex Charles City, Inc
Chattem Chemicals, Inc.
Coating Place, LLC
Mylan Pharmaceuticals Inc.
Neos Therapeutics Brands, LLC
Noven Therapeutics, LLC
PADAGIS US LLC
SpecGx LLC
Veranova, L.P.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 5 drug and cosmetic product listings (FDA).

  • Methylphenidate Transdermal System
  • Daytrana
  • Cotempla XR-ODT
  • Methylphenidate
  • Methylphenidate Hydrochloride
FDA Shortage Status
Active Shortage
Shortage History
current

Methylphenidate Hydrochloride Tablet, Extended Release

07/26/2023

Unavailable

current

Methylphenidate Hydrochloride Tablet, Extended Release

07/26/2023

Available

current

Methylphenidate Film, Extended Release

02/28/2025

Available

current

Methylphenidate Hydrochloride Tablet, Extended Release

07/26/2023

Limited Availability

Chemical Identity

CAS113-45-1
PubChem CID4158
DTXSIDDTXSID5023299
FormulaC14H19NO2
Mol. Weight233.31 g/mol
SMILESCOC(=O)C(C1CCCCN1)C2=CC=CC=C2

Data Sources

41582026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/methylphenidate/cids/JSON

Archive: data/sources/pubchem_name/methylphenidate.json

CAS 113-45-12026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 113-45-12026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json